A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)

Conditions: Frontal Fibrosing Alopecia Interventions: Drug: Baricitinib 4 MG Oral Tablet Sponsors: University of Alabama at Birmingham; Eli Lilly and Company Not yet recruiting

https://clinicaltrials.gov/study/NCT06240351

Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials

More News: Alopecia | Research | Study